エピソード

  • Complement inhibition PART TWO
    2026/06/15

    In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Complement inhibition: A whole new world,” lead author Dr. Nicholas Salupo, and senior author, Dr. Ali Mehdi, Cleveland Clinic, join moderator Dr. Narbeh Melikian, Cleveland Clinic London. The trio discusses the complement system, a central component of the innate immune system, and bridge to the adaptive immune system.

    続きを読む 一部表示
    17 分
  • Complement inhibition PART ONE
    2026/05/29

    In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Complement inhibition: A whole new world,” lead author Dr. Nicholas Salupo, and senior author, Dr. Ali Mehdi, Cleveland Clinic, join moderator Dr. Narbeh Melikian, Cleveland Clinic London. The trio discusses the complement system, a central component of the innate immune system, and bridge to the adaptive immune system.

    続きを読む 一部表示
    16 分
  • Update on antiobesity medications in adults PART TWO
    2026/03/31

    In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Update on antiobesity pharmacotherapy in adults: Current and emerging options,” Dr. Farah Ziyadeh, and Dr. Yael Mauer, Cleveland Clinic, join moderator Dr. Craig Nielsen, Cleveland Clinic. The trio discusses available antiobesity medications, including the incretin mimetics, and emerging antiobesity medications currently under investigation.

    続きを読む 一部表示
    19 分
  • Update on antiobesity medications in adults PART ONE
    2026/02/28

    In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Update on antiobesity pharmacotherapy in adults: Current and emerging options,” Dr. Farah Ziyadeh, and Dr. Yael Mauer, Cleveland Clinic, join moderator Dr. Craig Nielsen, Cleveland Clinic. The trio discusses available antiobesity medications, including the incretin mimetics, and emerging antiobesity medications currently under investigation.

    続きを読む 一部表示
    19 分
  • Lipoprotein(a) in clinical practice
    2026/01/31

    Listen as Dr. Astefanos Al-Dalakta and Dr. Ashish Sarraju, Cleveland Clinic, join moderator Dr. George Thomas, Cleveland Clinic, to discuss what clinicians need to know about lipoprotein(a) in clinical practice. Topics discussed include summarizes evidence on risk, screening strategies, and evolving therapies for elevated lipoprotein(a).

    続きを読む 一部表示
    24 分
  • Testing for PFAS ‘forever chemicals’ PART TWO
    2025/12/17

    This two-part podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Philip Zuccaro, BS, and Vasilis Vasiliou, PhD, both of the Yale School of Public Health, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Does my patient need testing for PFAS ‘forever chemicals’?”

    続きを読む 一部表示
    16 分
  • Testing for PFAS ‘forever chemicals’ PART ONE
    2025/11/17

    This two-part podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Philip Zuccaro, BS, and Vasilis Vasiliou, PhD, both of the Yale School of Public Health, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Does my patient need testing for PFAS ‘forever chemicals’?”

    続きを読む 一部表示
    15 分
  • Single-pill combination antihypertensive therapy
    2025/10/27

    This podcast moderated by Dr. Craig Nielsen features a discussion with Dr. Maximilian C. Volk, and Dr. Luke J. Laffin, Cleveland Clinic on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Should I consider Cy for my patient with high blood pressure?”

    続きを読む 一部表示
    25 分